BY Ron Gilmore

MD Anderson Cancer Center and Guardant Health recently announced a multi-year partnership designed to more quickly make comprehensive liquid biopsy technology the standard of care in cancer treatment. The commercial, research and development agreement makes MD Anderson one of the few hospitals in the world with integrated comprehensive liquid biopsy (CLB) capabilities.

While standard biopsies are considered an invasive procedure...

liquid biopsies cancer diagnosis